Classen Immunotherapies

Classen Immunotherapies is a biotechnology company based in Baltimore, Maryland, that specializes in the study of the relationship between vaccination schedules and the development of chronic immune-mediated diseases. Founded by Dr. John Barthelow Classen, the company holds an extensive portfolio of patents covering methods for monitoring and timing vaccinations to minimize the risk of disorders such as Type 1 diabetes and metabolic syndrome. The company's business model primarily focuses on the licensing and enforcement of its intellectual property related to immunization protocols and safety monitoring. Classen Immunotherapies is notably recognized for its high-profile patent litigation against major pharmaceutical companies, which has significantly influenced legal precedents regarding the patentability of medical methods.